Screening for chronic kidney disease in emerging countries: feasibility and hurdles

The Burden of Chronic Kidney Disease on Developing Nations: A 21st Century Challenge in Global Health

“…Stages 1 and 2 of CKD (covert CKD), as defined by the level of kidney function, are often asymptomatic and diagnosed by the presence of micro- and macroalbuminuria, which are markers for diffuse vascular damage and microinflammation associated with cardiokidney damage [13]. Covert CKD diagnosis is often a result of routine screening practices and generally targeted at high-risk patients [16]. …”

Epidemiology of Chronic Kidney Disease in Northern Region of Senegal: A Community-Based Study in 2012

“…Interestingly, one CKD patient over nine in our study was detected at early stages where therapeutic interventions are most efficient [2,10]. In developing countries, diagnosis of patients at ESRD has a limited interest because a few proportions of them will have access to renal replacement therapy with a lot of difficulties [18].…”

“…This study is the first one that assessed in a sample of Senegalese population the burden of CKD particularly for the early stages (1 and 2) which are often not seen by specialists at hospital [10].…”

Dia Mundial do Rim 2011: proteja seus rins, salve seu coração

“…There is now compelling evidence that including selective screening for CKD in global health programs designed primarily to reduce CVD will significantly improve the outcomes of not only renal disease, but especially the NCDs like diabetes and CVD that dominate future health care strategies. Roadmaps for accomplishing this have already been presented for both developed 39,40 and emerging 1,41 countries. However, effective implementation of such strategies will only come when both the general public and the renal community work together to convince health authorities it is in the public interest to do this.…”